RESUMEN
Butirosin, an aminoglycoside antibiotic produced by Bacillus circulans, bears the unique (S)-4-amino-2-hydroxybutyrate (AHBA) side chain, which protects the antibiotic from several common resistance mechanisms. The AHBA side chain is advantageously incorporated into clinically valuable antibiotics such as amikacin and arbekacin by synthetic methods. Therefore, it is of significant interest to explore the biosynthetic origins of this useful moiety. We report here that the AHBA side chain of butirosin is transferred from the acyl carrier protein (ACP) BtrI to the parent aminoglycoside ribostamycin as a gamma-glutamylated dipeptide by the ACP:aminoglycoside acyltransferase BtrH. The protective gamma-glutamyl group is then cleaved by BtrG via an uncommon gamma-glutamyl cyclotransferase mechanism. The application of this pathway to the in vitro enzymatic production of novel AHBA-bearing aminoglycosides is explored with encouraging implications for the preparation of unnatural antibiotics via directed biosynthesis.
Asunto(s)
Bacillus/metabolismo , Sulfato de Butirosina/biosíntesis , Proteína Transportadora de Acilo/metabolismo , Aminoácidos/metabolismo , Aminoglicósidos/metabolismo , Bacillus/enzimología , Proteínas Bacterianas/química , Proteínas Bacterianas/genética , Sulfato de Butirosina/química , Sulfato de Butirosina/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/genéticaRESUMEN
The chemoenzymatic installation of the clinically valuable (S)-4-amino-2-hydroxybutyryl side chain onto a number of 2-deoxystreptamine-containing aminoglycosides is described using the purified Bacillus circulans biosynthetic enzymes BtrH and BtrG in combination with a synthetic acyl-SNAC surrogate substrate.
Asunto(s)
Aminoglicósidos/síntesis química , Antibacterianos/síntesis química , Acilación , Proteínas Bacterianas/metabolismo , Sulfato de Butirosina/síntesis química , Sulfato de Butirosina/farmacología , Indicadores y Reactivos , Proteínas de Transporte de Membrana/metabolismo , Transaminasas/metabolismoAsunto(s)
Antibacterianos/biosíntesis , Bacterias/enzimología , Transglutaminasas/metabolismo , Bacterias/genética , Bacterias/metabolismo , Catálisis , Genes Bacterianos/genética , Familia de Multigenes/genética , Péptido Sintasas/química , Péptido Sintasas/genética , Péptido Sintasas/metabolismo , Polienos/química , Polienos/metabolismo , Pirroles/química , Pirroles/metabolismo , Transglutaminasas/química , Transglutaminasas/genéticaRESUMEN
Butirosins A and B are naturally occurring aminoglycoside antibiotics that have a (2S)-4-amino-2-hydroxybutyrate (AHBA) side chain. Semisynthetic addition of AHBA to clinically valuable aminoglycoside antibiotics has been shown both to improve their pharmacological properties and to prevent their deactivation by a number of aminoglycoside-modifying enzymes involved in bacterial resistance. We report here that the biosynthesis of AHBA from L-glutamate, encoded within a previously identified butirosin biosynthetic gene cluster, proceeds via intermediates tethered to a specific acyl carrier protein (ACP). Five components of the pathway have been purified and characterized, including the ACP (BtrI), an ATP-dependent ligase (BtrJ), a pyridoxal phosphate-dependent decarboxylase (BtrK), and a two-component flavin-dependent monooxygenase system (BtrO and the previously unreported BtrV). The proposed biosynthetic pathway includes a gamma-glutamylation of an ACP-derived gamma-aminobutyrate intermediate, possibly a rare example of protective group chemistry in biosynthesis.
Asunto(s)
Proteína Transportadora de Acilo/metabolismo , Aminoácidos/metabolismo , Sulfato de Butirosina/biosíntesis , Sulfato de Butirosina/química , Acilación , Aminoácidos/química , Aminobutiratos/química , Aminobutiratos/metabolismo , Antibacterianos/química , Antibacterianos/metabolismo , Bacillus/química , Bacillus/metabolismo , Ácido Glutámico/química , Ácido Glutámico/metabolismo , Hidroxilación , Estructura Molecular , Familia de MultigenesAsunto(s)
Aminoglicósidos/metabolismo , Bacillus/enzimología , Proteínas Bacterianas/metabolismo , Sulfato de Butirosina/biosíntesis , Glucosamina/metabolismo , Secuencia de Aminoácidos , Proteínas Bacterianas/química , Sulfato de Butirosina/química , Histona Desacetilasas/química , Datos de Secuencia Molecular , Homología de Secuencia de AminoácidoRESUMEN
Proper subcellular localization of focal adhesion kinase (FAK) is crucial for many cellular processes. It remains, however, unclear how FAK activity is regulated at subcellular compartments. To visualize the FAK activity at different membrane microdomains, we develop a fluorescence resonance energy transfer (FRET)-based FAK biosensor, and target it into or outside of detergent-resistant membrane (DRM) regions at the plasma membrane. Here we show that, on cell adhesion to extracellular matrix proteins or stimulation by platelet-derived growth factor (PDGF), the FRET responses of DRM-targeting FAK biosensor are stronger than that at non-DRM regions, suggesting that FAK activation can occur at DRM microdomains. Further experiments reveal that the PDGF-induced FAK activation is mediated and maintained by Src activity, whereas FAK activation on cell adhesion is independent of, and in fact essential for the Src activation. Therefore, FAK is activated at membrane microdomains with distinct activation mechanisms in response to different physiological stimuli.
Asunto(s)
Membrana Celular/química , Membrana Celular/enzimología , Transferencia Resonante de Energía de Fluorescencia/métodos , Proteína-Tirosina Quinasas de Adhesión Focal/química , Proteína-Tirosina Quinasas de Adhesión Focal/metabolismo , Animales , Adhesión Celular , Membrana Celular/genética , Activación Enzimática , Proteína-Tirosina Quinasas de Adhesión Focal/genética , Ratones , Ratones Noqueados , Factor de Crecimiento Derivado de Plaquetas/metabolismo , Estructura Terciaria de ProteínaRESUMEN
BACKGROUND: Recent studies have shown that blood monocytes harbor human immunodeficiency virus type 1 (HIV-1) variants that are genotypically distinguishable from those in CD4(+) T cells. However, the biological function of monocyte-derived HIV-1 remains unclear. METHODS: Using pseudovirus assay, we analyzed the phenotype conferred by monocyte-derived HIV-1 envelopes from 8 patients. RESULTS: All pseudoviruses carrying monocyte-derived HIV-1 envelopes used CCR5; however, their use of additional coreceptors delineated 4 phenotypes in which viruses used (1) CCR5 only, (2) CCR5 and CXCR4, (3) CCR3 and CCR5, or (4) multiple coreceptors, including CCR1, CCR3, GPR15, CCR5, and CXCR4. More importantly, we observed 2 distinct cell tropism phenotypes for pseudoviruses carrying monocyte-derived envelopes: (1) monocyte-derived, macrophage-specific R5 (MDMS-R5) virus that, using CCR5 only, could infect monocyte-derived macrophages (MDMs) but not CD4(+) T cells and (2) dual tropic virus that infected both MDMs and primary CD4(+) T cells. We found blood monocytes harboring viruses with multiple phenotypes as early as 25 days before seroconversion and as late as 9 years after seroconversion. CONCLUSIONS: These data suggest that HIV-1 circulating in blood monocytes represents diverse HIV-1 with multiple phenotypes and that MDMS-R5 viruses may play an important role in infection with and persistence of HIV-1 within the monocyte/macrophage lineage.
Asunto(s)
VIH-1/clasificación , Macrófagos/virología , Monocitos/virología , Receptores CCR5/metabolismo , Adulto , Secuencia de Aminoácidos , Linfocitos T CD4-Positivos/virología , Femenino , Proteína gp120 de Envoltorio del VIH/química , Proteína gp120 de Envoltorio del VIH/genética , Infecciones por VIH , VIH-1/aislamiento & purificación , VIH-1/metabolismo , VIH-1/patogenicidad , Humanos , Masculino , Persona de Mediana Edad , Fragmentos de Péptidos/química , Fragmentos de Péptidos/genética , Fenotipo , Alineación de SecuenciaRESUMEN
The proteins Neo-11 and Neo-18 encoded in the neomycin gene cluster (neo) of Streptomyces fradiae NCIMB 8233 have been characterized as glucosaminyl-6'-oxidase and 6'-oxoglucosaminyl:L-glutamate aminotransferase, respectively. The joint activity of Neo-11 and Neo-18 is responsible for the conversion of paromamine to neamine in the biosynthetic pathway of neomycin through a mechanism of FAD-dependent dehydrogenation followed by a pyridoxal-5'-phosphate-mediated transamination. Neo-18 is also shown to catalyze deamination at C-6''' of neomycin, thus suggesting bifunctional roles of the two enzymes in the formation of both neosamine rings of neomycin. The product of the btrB gene, a homologue of neo-18 in the butirosin biosynthetic gene cluster (btr) in Bacillus circulans, exhibits the same activity as Neo-18; this indicates that there is a similar reaction sequence in both butirosin and neomycin biosynthesis.
Asunto(s)
Antibacterianos/biosíntesis , Sulfato de Butirosina/biosíntesis , Glucosamina/análogos & derivados , Neomicina/biosíntesis , Oxidorreductasas/química , Transaminasas/química , Bacillus/enzimología , Bacillus/genética , Secuencia de Carbohidratos , Ciclización , Glucosamina/química , Glucosamina/clasificación , Datos de Secuencia Molecular , Familia de Multigenes , Oxidorreductasas/genética , Oxidorreductasas/metabolismo , Streptomyces/enzimología , Streptomyces/genética , Transaminasas/genética , Transaminasas/metabolismoRESUMEN
The 2-deoxystreptamine-containing aminoglycosides are an important class of clinically valuable antibiotics. A deep understanding of the biosynthesis of these natural products is required to enable efforts to rationally manipulate and engineer the biological production of novel aminoglycosides. This review discusses the development of our biosynthetic knowledge over the past half-century, with emphasis on the relatively recent contributions of molecular biology to the elucidation of these biosynthetic pathways.
Asunto(s)
Aminoglicósidos/biosíntesis , Antibacterianos/biosíntesis , Aminoglicósidos/química , Antibacterianos/química , Hexosaminas/biosíntesis , Estructura MolecularRESUMEN
Macaques were immunized with SF162 Env-based gp140 immunogens and challenged simultaneously with the CCR5-tropic homologous SHIV(SF162P4) and the CXCR4-tropic heterologous SHIV(SF33A) viruses. Both mock-immunized and immunized animals became dually infected. Prior immunization preferentially reduced the viral replication of the homologous virus during primary infection but the relative replication of the two coinfecting viruses during chronic infection was unaffected by prior immunization, despite the fact that five of six immunized animals maintained a significantly lower overall viral replication that the control animals. Neutralizing antibodies participated in controlling the replication of SHIV(SF162P4), but not that of SHIV(SF33A). Dual infection resulted in the emergence and predominance within the circulating CCR5 virus pool, of a variant with a distinct neutralization phenotype. The signature of this variant was the presence of three amino acid changes in gp120, two of which were located in the receptor and coreceptor binding sites. Also, a significant fraction of the viruses circulating in the blood, as early as two weeks post-infection, was recombinants and prior immunization did not prevent their emergence. These findings provide new insights into the dynamic interaction of CCR5- and CXCR4-tropic HIV isolates that are potentially relevant in better understanding HIV-mediated pathogenesis.